DC
MYGN icon

Deere & Company’s Myriad Genetics MYGN Stock Holding History

Deere & Company’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-50,073
Closed -$1.95M – 1020
2014
Q2 		$1.95M Sell
50,073
-5,570
-10% -$207K 0.11% 189
2014
Q1 		$1.9M Sell
55,643
-18,261
-25% -$566K 0.11% 185
2013
Q4 		$1.55M Buy
73,904
+10,227
+16% +$259K 0.08% 257
2013
Q3 		$1.5M Buy
63,677
+24,717
+63% +$702K 0.09% 235
2013
Q2 		$1.05M Buy
+38,960
New +$1.13M 0.06% 323

Other funds holding MYGN

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Deere & Company's MYGN Position: Q3 2014 in Review

Deere & Company sold out of Myriad Genetics (MYGN) in Q3 2014, closing a stake of 50,073 shares — an estimated $1.95M sold.

Deere & Company first reported a position in MYGN in Q2 2013 and held it in 5 quarters. The position peaked at $1.95M in Q2 2014. 275 funds tracked by Wall St. Rank hold MYGN as of Q3 2014.

  • Deere & Company reported no remaining Myriad Genetics position as of Q3 2014 after selling out during the quarter.
  • Deere & Company sold 50,073 Myriad Genetics shares in Q3 2014, an estimated $1.95M.
  • Deere & Company first reported a position in Myriad Genetics in Q2 2013 and held it in 5 quarters.
  • Deere & Company's Myriad Genetics position peaked at $1.95M in Q2 2014.
  • 275 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2014.

Based on Deere & Company's 13F filing for Q3 2014, filed 12 Nov 2014.